Siemens Healthineers Begins Transition Toward Standalone Olyrian Diagnostics Business

The new name will be introduced in stages as the business prepares to become a standalone organization. Separately, Siemens Healthineers has announced plans to change its name to Healthineers.

Olyrian Diagnostics aims to advance diagnostics across the care continuum, from the laboratory to the point of care, by combining intelligent technology with the expertise of professionals who generate, interpret, and act on diagnostic information. Its current portfolio includes laboratory automation, informatics, and point-of-care testing solutions.

The transition is expected to be completed by mid-2028, with Olyrian Diagnostics remaining part of Siemens Healthineers until then. Throughout this period, products and services, contracts, service levels, and customer points of contact will remain unchanged.

The Siemens Healthineers diagnostics business was established after acquisitions in 2006 and 2007, with legacy histories dating back to as early as 1884. Today, the business manufactures more than 16 billion tests annually across an assay portfolio that addresses nearly every major disease area. Its innovation history includes the first urine test strip for diabetes and the industry’s first automated, integrated clinical chemistry and immunoassay analyzer.

“Technology creates possibilities, but people turn those possibilities into better care and outcomes for patients. Every day, at the heart of care in the laboratory, we support care teams as they provide critical answers patients need. Whether someone is running a test, interpreting a result, or deciding what happens next, informed and connected workflows help drive efficiency and empower a more comprehensive understanding of patient health. Olyrian Diagnostics is how we’ll define our next chapter. We’re proud of our history and excited by our future,” said Sharon Bracken, head of Diagnostics for Siemens Healthineers.